Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 20477415)

1.

Early detection of ovarian cancer.

Das PM, Bast RC Jr.

Biomark Med. 2008 Jun;2(3):291-303. doi: 10.2217/17520363.2.3.291.

2.

Early detection of cancer: past, present, and future.

Schiffman JD, Fisher PG, Gibbs P.

Am Soc Clin Oncol Educ Book. 2015;35:57-65. doi: 10.14694/EdBook_AM.2015.35.57.

3.

"Less is more:" The harms of overtreatment in early ovarian cancer.

Temkin SM.

Gynecol Oncol. 2015 May;137(2):191-2. doi: 10.1016/j.ygyno.2015.04.007. No abstract available.

PMID:
25953509
4.

Fluorescence analysis of urine and its potential for ovarian cancer screening.

Martinicky D, Zvarik M, Sikurova L, Lajdova I, Hunakova L.

Neoplasma. 2015;62(3):500-6. doi: 10.4149/neo_2015_060.

PMID:
25869797
5.
6.

A multiplexable, microfluidic platform for the rapid quantitation of a biomarker panel for early ovarian cancer detection at the point-of-care.

Shadfan BH, Simmons AR, Simmons GW, Ho A, Wong J, Lu KH, Bast RC Jr, McDevitt JT.

Cancer Prev Res (Phila). 2015 Jan;8(1):37-48. doi: 10.1158/1940-6207.CAPR-14-0248. Epub 2014 Nov 11.

PMID:
25388014
7.

Ovarian cancer biomarker discovery based on genomic approaches.

Lee JY, Kim HS, Suh DH, Kim MK, Chung HH, Song YS.

J Cancer Prev. 2013 Dec;18(4):298-312. Review.

8.

Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategies.

Timms JF, Arslan-Low E, Kabir M, Worthington J, Camuzeaux S, Sinclair J, Szaub J, Afrough B, Podust VN, Fourkala EO, Cubizolles M, Kronenberg F, Fung ET, Gentry-Maharaj A, Menon U, Jacobs I.

Proteomics Clin Appl. 2014 Dec;8(11-12):982-93. doi: 10.1002/prca.201400063. Epub 2014 Nov 10.

PMID:
25290619
9.

In 2014, can we do better than CA125 in the early detection of ovarian cancer?

Cohen JG, White M, Cruz A, Farias-Eisner R.

World J Biol Chem. 2014 Aug 26;5(3):286-300. doi: 10.4331/wjbc.v5.i3.286. Review.

10.

[Screening for ovarian cancer in BRCA1/BRCA2 mutations carriers].

Synowiec A, Wcisło G, Bodnar L, Gasowska-Bodnar A, Szczylik C.

Ginekol Pol. 2014 May;85(5):377-81. Review. Polish.

PMID:
25011220
11.

Recent developments in proteomic methods and disease biomarkers.

Bergman N, Bergquist J.

Analyst. 2014 Aug 21;139(16):3836-51. doi: 10.1039/c4an00627e.

PMID:
24975697
12.

Transvaginal ultrasonography in ovarian cancer screening: current perspectives.

van Nagell JR Jr, Hoff JT.

Int J Womens Health. 2013 Dec 20;6:25-33. doi: 10.2147/IJWH.S38347. Review.

13.

Ovarian cancer screening--current status, future directions.

Menon U, Griffin M, Gentry-Maharaj A.

Gynecol Oncol. 2014 Feb;132(2):490-5. doi: 10.1016/j.ygyno.2013.11.030. Epub 2013 Dec 3. Review.

14.

A 2-stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value.

Lu KH, Skates S, Hernandez MA, Bedi D, Bevers T, Leeds L, Moore R, Granai C, Harris S, Newland W, Adeyinka O, Geffen J, Deavers MT, Sun CC, Horick N, Fritsche H, Bast RC Jr.

Cancer. 2013 Oct 1;119(19):3454-61. doi: 10.1002/cncr.28183. Epub 2013 Aug 26.

15.

Vascular endothelial growth factor (VEGF) improves the sensitivity of CA125 for differentiation of epithelial ovarian cancers from ovarian cysts.

Robati M, Ghaderi A, Mehraban M, Shafizad A, Nasrolahi H, Mohammadianpanah M.

Arch Gynecol Obstet. 2013 Oct;288(4):859-65. doi: 10.1007/s00404-013-2819-7. Epub 2013 Apr 7.

PMID:
23564055
16.

Biomarkers for early detection of ovarian cancer.

Nguyen L, Cardenas-Goicoechea SJ, Gordon P, Curtin C, Momeni M, Chuang L, Fishman D.

Womens Health (Lond Engl). 2013 Mar;9(2):171-85; quiz 186-7. doi: 10.2217/whe.13.2.

18.

Longitudinal screening algorithm that incorporates change over time in CA125 levels identifies ovarian cancer earlier than a single-threshold rule.

Drescher CW, Shah C, Thorpe J, O'Briant K, Anderson GL, Berg CD, Urban N, McIntosh MW.

J Clin Oncol. 2013 Jan 20;31(3):387-92. doi: 10.1200/JCO.2012.43.6691. Epub 2012 Dec 17.

19.

Nanotechnology: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(19):1-43. Epub 2006 Nov 1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk